Cytokine production in an ex vivo whole blood model following induction by group B streptococcal polysaccharides and lipoteichoic acid.
von Hunolstein
C
C
Istituto Superiore di Sanità, Roma, Italy.
Totolian
A
A
Alfarone
G
G
Teti
G
G
Orefici
G
G
D000328:Adult; D016207:Cytokines / Q000096:biosynthesis / Q000097:blood*; D006801:Humans; D066298:In Vitro Techniques; D007375:Interleukin-1 / Q000096:biosynthesis / Q000097:blood; D015850:Interleukin-6 / Q000096:biosynthesis / Q000097:blood; D016209:Interleukin-8 / Q000096:biosynthesis / Q000097:blood; D008070:Lipopolysaccharides / Q000633:toxicity*; D011135:Polysaccharides, Bacterial / Q000633:toxicity*; D013290:Streptococcal Infections / Q000209:etiology / Q000276:immunology; D013292:Streptococcus agalactiae / Q000276:immunology / Q000472:pathogenicity*; D013682:Teichoic Acids / Q000633:toxicity*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
D016207:Cytokines; D007375:Interleukin-1; D015850:Interleukin-6; D016209:Interleukin-8; D008070:Lipopolysaccharides; D011135:Polysaccharides, Bacterial; D013682:Teichoic Acids; D014409:Tumor Necrosis Factor-alpha; C009900:lipoteichoic acid